Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
DE69228061D1 - Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum - Google Patents
[go: Go Back, main page]

DE69228061D1 - Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum - Google Patents

Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum

Info

Publication number
DE69228061D1
DE69228061D1 DE69228061T DE69228061T DE69228061D1 DE 69228061 D1 DE69228061 D1 DE 69228061D1 DE 69228061 T DE69228061 T DE 69228061T DE 69228061 T DE69228061 T DE 69228061T DE 69228061 D1 DE69228061 D1 DE 69228061D1
Authority
DE
Germany
Prior art keywords
galactose
methods
sulfate
prediabetis
itselves
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69228061T
Other languages
English (en)
Other versions
DE69228061T2 (de
Inventor
Karsten Buschard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A+ Science AB
Original Assignee
A+ Science Invest AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A+ Science Invest AB filed Critical A+ Science Invest AB
Application granted granted Critical
Publication of DE69228061D1 publication Critical patent/DE69228061D1/de
Publication of DE69228061T2 publication Critical patent/DE69228061T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69228061T 1991-05-07 1992-05-07 Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum Expired - Fee Related DE69228061T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK91846A DK84691D0 (da) 1991-05-07 1991-05-07 Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
PCT/DK1992/000146 WO1992019633A1 (en) 1991-05-07 1992-05-07 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual

Publications (2)

Publication Number Publication Date
DE69228061D1 true DE69228061D1 (de) 1999-02-11
DE69228061T2 DE69228061T2 (de) 1999-05-27

Family

ID=8098211

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69228061T Expired - Fee Related DE69228061T2 (de) 1991-05-07 1992-05-07 Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum

Country Status (9)

Country Link
US (1) US5827828A (de)
EP (1) EP0584175B1 (de)
JP (1) JP3222465B2 (de)
AT (1) ATE175203T1 (de)
AU (1) AU1788892A (de)
DE (1) DE69228061T2 (de)
DK (2) DK84691D0 (de)
ES (1) ES2125898T3 (de)
WO (1) WO1992019633A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580858A (en) * 1991-06-10 1996-12-03 Alberta Research Council Immunosuppressive and tolerogenic modified Lewisx compounds
US5663151A (en) * 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
US5686426A (en) 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
SE9601817D0 (sv) * 1996-05-13 1996-05-13 Karsten Buschard Novel glycolipid complexex and their uses
JP3495740B2 (ja) * 1997-04-10 2004-02-09 麒麟麦酒株式会社 α−グリコシルセラミドを含有するＮＫＴ細胞活性化剤
US6492337B1 (en) 1997-12-30 2002-12-10 A+ Science Ab Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complication
SE0000258D0 (sv) 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
EP1437358B1 (de) 2001-08-16 2006-10-18 Daiichi Asubio Pharma Co., Ltd. Neues glykolipid, und heilmittel für autoimmunerkrankungen, das dieses als wirkstoff enthält
EP2040541B1 (de) * 2006-06-30 2016-03-23 The Scripps Research Institute Hilfsstoffe und verwendungsverfahren
FR2926972B1 (fr) * 2008-02-05 2011-03-11 Technologia Appareil de diagnostic precoce du syndrome du canal carpien et procede et dispositif d'acquisition de l'information relative a la sensibilite cutanee du doigt du patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288706A (en) * 1987-12-25 1994-02-22 Mitsui Toatsu Chemicals, Incorporated Medicament for prevention and remedy of diseases of the pancreas and others

Also Published As

Publication number Publication date
US5827828A (en) 1998-10-27
DE69228061T2 (de) 1999-05-27
JPH06506943A (ja) 1994-08-04
ATE175203T1 (de) 1999-01-15
JP3222465B2 (ja) 2001-10-29
ES2125898T3 (es) 1999-03-16
DK0584175T3 (da) 1999-08-30
EP0584175B1 (de) 1998-12-30
AU1788892A (en) 1992-12-21
DK84691D0 (da) 1991-05-07
WO1992019633A1 (en) 1992-11-12
EP0584175A1 (de) 1994-03-02

Similar Documents

Publication Publication Date Title
Eaton et al. Sickle cell hemoglobin polymerization
DE69228061D1 (de) Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum
Grandjean et al. Psychological dysfunctions in lead-exposed workers: relation to biological parameters of exposure
Schooley et al. Immunochemical studies of human urinary erythropoietin.
Campbell An improved method for the in vitro evaluation of monocyte leukotaxis
Alessio et al. Free erythrocyte protoporphyrin as an indicator of the biological effect of lead in adult males: III. Behavior of free erythrocyte protoporphyrin in workers with past lead exposure
Chuong et al. The MMPI as an aid in evaluating patients with premenstrual syndrome
Lorente et al. A simple and reproducible method to evaluate granulocyte adherence
Magro Blocking of histamine release from human basophils in vitro by the ATPase inhibitor, ethacrynic acid
Wang et al. Plasma arginase concentration measured by an enzyme-linked immunosorbent assay (ELISA) in normal adult population
NO963911D0 (no) Innretning for behandling av autoimmune sykdommer og fremgangsmåte for behandling
Bombardt et al. A GC/CIMS assay for the cis and trans isomers of thiothixene in human plasma.
Richards et al. Thyroid hormone and conditioning.
Koldzhiev et al. Determination of 131I-triiodothyronine absorption by erythrocytes
Bird Nature of cold agglutinin linkage
Sjöstrand The effect of oxygen at high pressure on thyroid function in the rat
JPS5443096A (en) Sample vessel for electrolyte analyser
ALEX Position lifetime studies of hydrogen embrittlement[Ph. D. Thesis]
Lu Solution of elastoplastic contact problem by boundary element method and mathematical programming technique
Friedman et al. EMOTIONAL ASPECTS OF RESPIRATORY DISORDERS IN COAL MINERS
SUNAGANE et al. Mechanism of relaxant action of papaverine. II. Differences between modes of relaxant effects of papaverine and amytal in guinea-pig taenia coli
de Lara et al. The inhibitory effect of immunoglobulin E on monoamine uptake in human platelets
Yachnin Further studies on the hemolysis of human red cells by late acting complement components
Dombrovskiĭ et al. Immunochemical methods of determining myoglobin in blood and urine
Kitada et al. Cardiac Arrhythmias among School Children Students: PROCEEDINGS OF THE III. CONFERENCE ON PREVENTION FOR RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee